4 completed, 2 unknown, 1 enrolling by invitation, 1 terminated. 3 Not applicable, 2 Phase 2, 2 Phase 4, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Completed 1, Enrolling by invitation 1, Unknown 1 |
| Phase 2 | 2 | Terminated 1, Unknown 1 |
| Phase 4 | 2 | Completed 2 |
| Phase 1 | 1 | Unknown 1 |
| Phase 3 | 1 | Completed 1 |
Follow Nucleotides: new trials by email Literature Review of Nucleotides trials Research Report on Nucleotides
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Immunonutrition for Surgical Prehabilitation of Patients With Upper GI Cancer Oral nutritional supplements with immunonutrition (enriched with arginine, nucleotides, vitamin D and omega-3-fatty acid), Standart of care - Upper GI Cancer | Not applicable | Enrolling by invitation | Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal | 110 | 2026-01-01 | 2026-10-20 |
| Peginterferon Alpha-2b Therapy in Chronic Hepatitis Patients With Normal ALT Level and Low Viremia Peginterferon alpha-2b, Nucleotide Analog, pulse peginterferon alpha-2b - Chronic Hepatitis B Patients With a Normal ALT Level and Low Viremia | Phase 1 / Phase 2 | Unknown | Fuzhou General Hospital | 300 | 2021-12-10 | 2022-01-24 |
| Evaluating the Safety and Efficacy of Inarigivir in Non-cirrhotic, Hepatitis B e Antigen-negative Subjects Infected With HBV Virus and Receiving or Stopping Treatment With a NUC Inhibitor Inarigivir soproxil, Nucleoside/nucleotide (NUC) analogue inhibitors - Hepatitis B, HBV | Phase 2 | Terminated | F-star Therapeutics, Inc. | 64 | 2019-06-18 | 2020-07-22 |
| To Optimize the Therapeutic Pathway of Peginterferon Treatment in Patients With CHB Based on IFNA2p.Ala120Thr /ISGs. Nucleotide Analog, Interferon Alfa-2A - Hepatitis B | Not applicable | Unknown | Sun Yat-sen University | 400 | 2018-12-01 | 2023-05-08 |
| Nucleotides and B Vitamins in the Treatment of Low Back Pain Nucleotides + B12, B Vitamins - Low Back Pain | Phase 4 | Completed | Fundação Educacional Serra dos Órgãos | 300 | 2016-03-01 | 2019-04-19 |
| Immunonutrition and Quality of Life of Cancer Patients Undergoing Oncological Treatment Nutritional supplements containing arginine, n-3 and nucleotides, Isocaloric control - Gastrointestinal Cancer | Phase 3 | Completed | Société des Produits Nestlé (SPN) | 300 | 2012-07-01 | 2015-11-13 |
| A Trial of 2 Options for Second Line Combination Antiretroviral Therapy Following Virological Failure of a Standard Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI)+2N(t)RTI First Line Regimen raltegravir, 2N(t)RTI, Ritonavir-boosted lopinavir - HIV Infections | Phase 4 | Completed | Kirby Institute | 558 | 2009-09-01 | 2026-03-27 |
| Clinical Effects of a Nucleotides-Supplemented Infant Formula Nutritional supplementation (nucleotides) - Nutritional Requirements | Not applicable | Completed | Soroka University Medical Center | 150 | 2006-03-01 | 2007-10-23 |
Gastrointestinal Neoplasms (2) · Hepatitis B (2) · Hepatitis B, Chronic (2) · Acquired Immunodeficiency Syndrome (1) · HIV Infections (1) · Low Back Pain (1) · Malnutrition (1) · Neoplasms (1)
F-star Therapeutics, Inc. (1) · Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal (1) · Fundação Educacional Serra dos Órgãos (1) · Fuzhou General Hospital (1) · Kirby Institute (1) · Société des Produits Nestlé (SPN) (1) · Soroka University Medical Center (1) · Sun Yat-sen University (1)
China (2) · France (2) · United Kingdom (2) · Argentina (1) · Australia (1) · Canada (1) · Chile (1) · Germany (1) · Hong Kong (1) · India (1) · Ireland (1) · Israel (1) · Malaysia (1) · Mexico (1) · New Zealand (1)
Brian Gazzard, MD (1) · Chan Xie (1) · Christophe Mariette, MD (1) · David A Cooper, MD (1) · Don Mitchell (1) · Marco AN Mibielli, MD (1) · Zvi Weizman, MD (1)
PMID 23769235, PMID 24204757, PMID 25723472, PMID 33399309, PMID 38923559